@article{9ed58e4def914b778e9f3792fbf7add5,
title = "A decade of pharma discovery delivers new tools targeting trace amine-associated receptor 1",
author = "Tallman, {Katie R.} and Grandy, {David K.}",
note = "Funding Information: In the past, emerging areas of neuroscience benefitted from contributions made by researchers in industry and academia. Unfortunately, this has not been true for TAAR1 over the past decade. In fact, TAAR1-related research is nearly at a standstill because of limited funding from the National Institutes of Health and other nonprofit entities. In the future, this will hopefully improve, in part due to Revel et al{\textquoteright}s two most recent publications, which will draw the attention of grant reviewers, funding agencies, and health policy makers to this exciting and important area of neuroscience research.",
year = "2012",
month = nov,
doi = "10.1038/npp.2012.148",
language = "English (US)",
volume = "37",
pages = "2553--2554",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "12",
}